Related Experiment Video
Updated: Jul 10, 2026
05:49
Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
Release, purification, and characterization of platelet-activating factor (PAF)
V Tencé1, J Polonsky, J P Le Couedic
1Centre National de la Recherche Scientifique, Gif-sur-Yvette and Institut National de la Santé et de la Recherche Médicale, Unité 131, Clamart (France).
Biochimie
|January 1, 1980
Summary
Platelet-activating factor (PAF) is released by immune cells and aggregates platelets. This study details optimal conditions for PAF release and its purification, identifying it as a specific glycerophospholipid.
Area of Science:
- Immunology
- Biochemistry
- Cell Biology
Background:
- Platelet-activating factor (PAF) is a potent phospholipid mediator released by various immune cells.
- PAF plays a crucial role in platelet aggregation and the release of vasoactive substances.
- Understanding PAF's release and structure is vital for immunological and inflammatory research.
Purpose of the Study:
- To investigate the spontaneous release of PAF from hog blood leukocytes.
- To establish optimal conditions for PAF release and develop a purification method.
- To elucidate the structural characteristics of PAF and differentiate it from other aggregating agents.
Main Methods:
- Studied spontaneous PAF release from hog leukocytes under varying conditions (temperature, pH, buffers).
- Utilized calcium chelators (EDTA) and phospholipase A2 inhibitors (bromophenacyl bromide) to study release mechanisms.
- Developed preparative extraction and purification using silicic acid columns and HPLC.
- Analyzed purified fractions using TLC and chemical ionization mass spectrometry.
Main Results:
- Optimal PAF release occurred at 22°C and pH 9.5 in BSA and Ca2+-containing Tyrode's solution.
- PAF release was inhibited by EDTA and bromophenacyl bromide, indicating a requirement for Ca2+ and active phospholipase A2.
- PAF is not a preformed mediator, as cell disruption did not yield PAF.
- Purification yielded active fractions, but contaminants (sphingomyelin, lysophosphatidylcholine) were present.
- PAF activity was unaffected by diazomethane, acetylation, or hydrogenation.
Conclusions:
- PAF is a glycerophospholipid lacking an ester function at position 1.
- Established precise criteria for distinguishing PAF from other platelet aggregating agents.
- The findings provide a foundation for understanding PAF's role in immune responses and developing targeted therapies.
